Mohammad Foad Heidary1, Hamideh Mahmoodzadeh Hosseini2, Elnaz Mehdizadeh Aghdam3, Mohammad Reza Nourani4, Reza Ranjbar1, Reza Mirnejad1, Abbas Ali Imani Fooladi2. 1. Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. 2. Applied Micobiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. 3. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. 4. Chemical Injury Research Center (CIRC), Baqiyatallah University of Medical Sciences, Tehran, Iran.
Abstract
PURPOSE: One of the advanced cancer therapy strategies is immune-stimulating compound based immunotherapy Staphylococcal enterotoxin B (SEB) is one of the potent superantigens, which can efficiently activate antitumor immune response to eradicate tumor growth and inhibit metastasis. Herein, we evaluated the effect of SEB on the expression of two master microRNAs, mir-335 and mir-10b, involved in metastasis. METHODS: A metastatic breast cancer cell line MDA-MB231was treated with four different concentrations of SEB, including 10, 10(2), 10(3) and 10(4) ng/ml, for 24 and 48 hours. To identify the cytotoxic effect of SEB, treated cells were examined by MTT assay. The stem loop RT-PCR (TaqMan) was used to analyze the mir-335 and mir-10b expression. RESULTS: RESULTS showed that SEB significantly increased the expression of mir-335 both after 24 and 48 hours (pv < 0.001 and pv < 0.05, respectively). No significant differences were found in the mir-10b expression. CONCLUSION: Moreover, our findings demonstrated no cytotoxic effect of SEB on the treated cells. Our results suggest that SEB probably induces its anti-metastatic effect via the expression regulation of the main genes which contributes to metastasis.
PURPOSE: One of the advanced cancer therapy strategies is immune-stimulating compound based immunotherapy Staphylococcal enterotoxin B (SEB) is one of the potent superantigens, which can efficiently activate antitumor immune response to eradicate tumor growth and inhibit metastasis. Herein, we evaluated the effect of SEB on the expression of two master microRNAs, mir-335 and mir-10b, involved in metastasis. METHODS: A metastatic breast cancer cell line MDA-MB231was treated with four different concentrations of SEB, including 10, 10(2), 10(3) and 10(4) ng/ml, for 24 and 48 hours. To identify the cytotoxic effect of SEB, treated cells were examined by MTT assay. The stem loop RT-PCR (TaqMan) was used to analyze the mir-335 and mir-10b expression. RESULTS: RESULTS showed that SEB significantly increased the expression of mir-335 both after 24 and 48 hours (pv < 0.001 and pv < 0.05, respectively). No significant differences were found in the mir-10b expression. CONCLUSION: Moreover, our findings demonstrated no cytotoxic effect of SEB on the treated cells. Our results suggest that SEB probably induces its anti-metastatic effect via the expression regulation of the main genes which contributes to metastasis.
Entities:
Keywords:
Breast Cancer; Metastasis; Mir-10b; Mir-335; Staphylococcal Enterotoxin B
Authors: Kim J Png; Mitsukuni Yoshida; Xiang H-F Zhang; Weiping Shu; Hyeseung Lee; Andreas Rimner; Timothy A Chan; Elizabeth Comen; Viktor P Andrade; Seok Won Kim; Tari A King; Clifford A Hudis; Larry Norton; James Hicks; Joan Massagué; Sohail F Tavazoie Journal: Genes Dev Date: 2011-02-01 Impact factor: 11.361
Authors: Hamideh Mahmoodzadeh Hosseini; Abbas Ali Imani Fooladi; Jafar Soleimanirad; Mohammad Reza Nourani; Soodabeh Davaran; Mehdi Mahdavi Journal: Tumour Biol Date: 2014-01-08
Authors: Hamideh Mahmoodzadeh Hosseini; Abbas Ali Imani Fooladi; Jafar Soleimanirad; Mohammad Reza Nourani; Mehdi Mahdavi Journal: J BUON Date: 2014 Apr-Jun Impact factor: 2.533
Authors: Abbas Ali Imani Fooladi; Morteza Sattari; Zuhair Mohammad Hassan; Mehdi Mahdavi; Taghi Azizi; Akira Horii Journal: Biotechnol Lett Date: 2008-07-24 Impact factor: 2.461
Authors: Elena A Pudova; George S Krasnov; Kirill M Nyushko; Anastasiya A Kobelyatskaya; Maria V Savvateeva; Andrey A Poloznikov; Daniyar R Dolotkazin; Kseniya M Klimina; Zulfiya G Guvatova; Sergey A Simanovsky; Nataliya S Gladysh; Artemy T Tokarev; Nataliya V Melnikova; Alexey A Dmitriev; Boris Y Alekseev; Andrey D Kaprin; Marina V Kiseleva; Anastasiya V Snezhkina; Anna V Kudryavtseva Journal: BMC Med Genomics Date: 2020-09-18 Impact factor: 3.063